March 9, 2021 Atomic Spectroscopy Licensing, IP, and Legal

Luminex Corporation to Participate at the 2021 Barclays Global Healthcare Conference

Luminex® Corporation (NASDAQ: LMNX) develops, manufactures, and markets proprietary biological testing technologies, with applications throughout the life-sciences industry. Luminex Corporation to Participate at the 2021 Barclays Global Healthcare Conference Mar 09, 2021 11:35 AM EST AUSTIN, Texas, March 9, 2021 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced that Homi Shamir, Chairman, CEO & President, and... Read more

March 9, 2021 Chromatography Lab Top-10 PAI Top-10

PerkinElmer Completes Acquisition of Oxford Immunotec Global PLC

WALTHAM, Mass.–(BUSINESS WIRE)–Mar. 9, 2021– PerkinElmer, Inc., (NYSE: PKI) a global leader committed to innovating for a healthier world, today announced that the Company has completed its previously announced acquisition of Oxford Immunotec Global PLC (Oxford Immunotec). PerkinElmer originally announced its intent to acquire Oxford Immunotec on January 7, 2021. “Oxford Immunotec’s global role in... Read more

March 9, 2021 Lab Top-10 Liq. Handling & Robotics Product Launch

PerkinElmer Launches Comprehensive Solutions for Detecting SARS-CoV-2 Mutations

Company expands SARS-CoV-2 assay portfolio with RT-PCR and next generation sequencing solutions to identify mutations associated with SARS-CoV-2 variants WALTHAM, Mass.–(BUSINESS WIRE)–Mar. 9, 2021– PerkinElmer, Inc. (NYSE:PKI) today announced the launch of two Research Use Only (RUO) solutions, PKamp™ VariantDetect™ SARS-CoV-2 RT-PCR Assay and Next Generation Sequencing-based NEXTFLEX® Variant-Seq™ SARS-CoV-2 Kit. Using nucleic acid extracted... Read more

March 8, 2021 Chemicals, Reagents & Kits Chromatography Environ, Ag./Food & Bev Lab Top-10 PAI Top-10

PerkinElmer Adds HPLC Columns to Consumables Portfolio

Delivering Full, Performance-Boosting Workflow Solutions for Pharma, Chemical, Food and Environmental Testing Labs WALTHAM, Mass. – March, 8, 2021 PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that it has added state-of-the-art columns and chemistries to its LC consumables portfolio by acquiring ES Industries, based in West Berlin, New... Read more

March 8, 2021 Chemicals, Reagents & Kits Informatics & Software Lab Top-10 Product Launch

Bruker Announces New Results in Deep, Unbiased Plasma Proteomics, PaSER 1.1 Software and New Cross-linking Consumables at US HUPO 2021

Roman Fischer of Oxford University demonstrates high-throughput 4D proteomicson non-depleted, untreated plasma identifying >350 protein groups with short 10-20 minute methods, enabling high throughput, robust biomarker discovery OmicEra Diagnostics reports running 720 undepleted serum samples from 31 COVID-19 patients over just 12 days on a single timsTOF Pro system at a rate of 60 samples/day,... Read more

March 8, 2021 Uncategorized

Roche provides update on Tecentriq US indication in prior-platinum treated metastatic bladder cancer

Basel, 8 March 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the company is voluntarily withdrawing the US indication for Tecentriq® (atezolizumab) in prior-platinum treated metastatic urothelial carcinoma (mUC, bladder cancer). This decision was made in consultation with the US Food and Drug Administration (FDA) as part of an industry-wide review of... Read more

March 7, 2021 Uncategorized

Happy International Women’s Day 2021

Celebrating female scientists On this International Women’s Day, March 8, 2021, ZEISS Research Microscopy takes a look back at the past year and the many inspiring women we have met whose sharp minds are advancing research across many different fields. Live Cell Imaging to Study Neuron Development Dr. Gabriela Toro is a postdoctoral research associate... Read more

March 5, 2021 Acad, Gov/Utilities Microscopy

Roche’s Actemra/RoActemra becomes the first biologic therapy approved by the FDA for slowing the rate of decline in pulmonary function in adults with systemic sclerosis-associated interstitial lung disease, a rare, debilitating condition

Systemic sclerosis (SSc) is a rare disease that affects about 2.5 million people worldwide Approximately 80% of SSc patients may be affected by interstitial lung disease (ILD), a progressive disease that can significantly impact lung function and can be life-threatening In a global study, Actemra/RoActemra reduced the rate of progressive loss of lung function in... Read more